{# max-image-preview:large is what makes an article eligible for the big-image card in Google Discover — without it Google may only show a thumbnail. #} {# ── Google Preferred Sources ──────────────────────────────────────────── Readers who mark us as a preferred source get our fresh articles prioritised in Top Stories, Discover and Google News. Only domain- and subdomain-level sites are eligible — blog.alfafinder.com qualifies, a /news/ subdirectory would not. #}

Tatva Chintan Pharma Chem — Latest News

Every announcement Tatva Chintan Pharma Chem has filed with the exchanges that we have reported, newest first. Each story links the original filing.

NSE: TATVA BSE: 543321 Chemicals & Petrochemicals 2 stories

Price

₹1713.7

Market Cap

₹4,008.70 Cr

Revenue TTM

₹556.05

P/E (TTM)

78.01×

Sector 44.63×

Reference data from Trendlyne, as of the most recent story. Not a valuation or a recommendation.

Expansion · 2
Expansion

Tatva Chintan Pharma Chem Commences New Greenfield Unit at Dahej-III in Gujarat

Tatva Chintan Pharma Chem holds groundbreaking for its Dahej-III greenfield unit. The expansion aims to boost infrastructure and meet rising chemical…
Expansion

Tatva Chintan Pharma Chem Approves Rs 200 Crore Greenfield Expansion in Gujarat

Tatva Chintan Pharma Chem Limited approves a Rs 200 Crore greenfield expansion at Dahej-III to add 344 KL reactor capacity over 21 months for special…

Track Tatva Chintan Pharma Chem in real time

ALFA Finder watches NSE & BSE filings 24/7 and alerts you the moment Tatva Chintan Pharma Chem files something material.

Start Free — 15-day trial
{# ── Promo popup — fires 5s after first page load per session. NEVER fires for visitors arriving from a search engine: a full-viewport overlay on a news article is an intrusive interstitial, and Google News policy is explicit that promotional material must not exceed the content. Direct, social and referral traffic still sees it. ─────────── #}